Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maja Beck-Popovic

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Preliminary experience in treatment of papillary and macular retinoblastoma: evaluation of local control and local complications after treatment with linear accelerator-based stereotactic radiotherapy with micromultileaf collimator as second-line or salvage treatment after chemotherapyAlessia Pica, Raphael Moeckli, Aubin Balmer, et al.
Journal of Translational Medicine|September 7, 2023
CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (<sup>123/131</sup>I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumorsJoana Grand-Guillaume, Rosalba Mansi, Raghuvir H Gaonkar, et al.
Swiss Medical Weekly|April 25, 2006
Unlicensed and off-label drug use in a Swiss paediatric university hospitalErmindo R Di Paolo, Hans Stoetter, Jacques Cotting, et al.
European Journal of Haematology|April 11, 2007
The prognostic significance of cytogenetic aberrations in childhood acute myeloid leukaemia. A study of the Swiss Paediatric Oncology Group (SPOG)David R Betts, Roland A Ammann, Andreas Hirt, et al.
Journal of Bioethical Inquiry|October 13, 2017
Parents' and Physicians' Perceptions of Children's Participation in Decision-making in Paediatric Oncology: A Quantitative StudyMichael Rost, Tenzin Wangmo, Felix Niggli, et al.
Pediatric Hematology and Oncology|November 9, 2021
PASTEC - a prospective, single-center, randomized, cross-over trial of pure physical versus physical plus attentional training in children with cancerAndrea Fontana, Sonia Matthey, Claire Mayor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group databaseRochelle Bagatell, Maja Beck-Popovic, Wendy B London, et al.
World Neurosurgery|January 24, 2023
Predictive Factors for the Occurrence of Perioperative Complications in Pediatric Posterior Fossa TumorsStephanie Anetsberger, Amine Mellal, Marta Garvayo, et al.
Frontiers in Endocrinology|December 19, 2022
Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertensionAnnick Mühlethaler-Mottet, Silvia Uccella, Deborah Marchiori, et al.
Cancers|July 24, 2021
Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG)Christina Stathopoulos, Livia Lumbroso-Le Rouic, Annette C Moll, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Preliminary experience in treatment of papillary and macular retinoblastoma: evaluation of local control and local complications after treatment with linear accelerator-based stereotactic radiotherapy with micromultileaf collimator as second-line or salvage treatment after chemotherapyAlessia Pica, Raphael Moeckli, Aubin Balmer, et al.
Journal of Translational Medicine|September 7, 2023
CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (<sup>123/131</sup>I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumorsJoana Grand-Guillaume, Rosalba Mansi, Raghuvir H Gaonkar, et al.
Swiss Medical Weekly|April 25, 2006
Unlicensed and off-label drug use in a Swiss paediatric university hospitalErmindo R Di Paolo, Hans Stoetter, Jacques Cotting, et al.
European Journal of Haematology|April 11, 2007
The prognostic significance of cytogenetic aberrations in childhood acute myeloid leukaemia. A study of the Swiss Paediatric Oncology Group (SPOG)David R Betts, Roland A Ammann, Andreas Hirt, et al.
Journal of Bioethical Inquiry|October 13, 2017
Parents' and Physicians' Perceptions of Children's Participation in Decision-making in Paediatric Oncology: A Quantitative StudyMichael Rost, Tenzin Wangmo, Felix Niggli, et al.
Pediatric Hematology and Oncology|November 9, 2021
PASTEC - a prospective, single-center, randomized, cross-over trial of pure physical versus physical plus attentional training in children with cancerAndrea Fontana, Sonia Matthey, Claire Mayor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group databaseRochelle Bagatell, Maja Beck-Popovic, Wendy B London, et al.
World Neurosurgery|January 24, 2023
Predictive Factors for the Occurrence of Perioperative Complications in Pediatric Posterior Fossa TumorsStephanie Anetsberger, Amine Mellal, Marta Garvayo, et al.
Frontiers in Endocrinology|December 19, 2022
Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertensionAnnick Mühlethaler-Mottet, Silvia Uccella, Deborah Marchiori, et al.
Cancers|July 24, 2021
Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG)Christina Stathopoulos, Livia Lumbroso-Le Rouic, Annette C Moll, et al.
Pageof 10